Abstract
This paper describes the development and validation of a HPLC-UV method (210 nm) for the simultaneous quantitation of artemether and lumefantrine in fixed dose combination tablets. The method showed to be linear (r(2)>0.99), precise (R.S.D.<2.0%), accurate (recovery of 101.07% for artemether and 101.58% for lumefantrine), specific and robust. Four batches of artemether-lumefantrine tablets were assayed by the validated method. The artemether contents in the tablets varied from 98.61% to 103.35%, while lumefantrine contents were 97.92-100.48%.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antimalarials / analysis*
-
Antimalarials / chemistry
-
Artemether
-
Artemisinins / analysis*
-
Artemisinins / chemistry
-
Chromatography, High Pressure Liquid / methods*
-
Dosage Forms
-
Drug Combinations
-
Ethanolamines / analysis*
-
Ethanolamines / chemistry
-
Fluorenes / analysis*
-
Fluorenes / chemistry
-
Lumefantrine
-
Molecular Structure
-
Reference Standards
-
Reproducibility of Results
-
Sensitivity and Specificity
-
Spectrophotometry, Ultraviolet / methods*
-
Tablets / analysis
Substances
-
Antimalarials
-
Artemisinins
-
Dosage Forms
-
Drug Combinations
-
Ethanolamines
-
Fluorenes
-
Tablets
-
Artemether
-
Lumefantrine